Note
The Scientific Committee of the Asian Society for Neuro-Oncology (ASNO) 2026 invites the submission of abstracts for oral and poster presentations.
All abstracts must be submitted in English via the online submission system.
This conference will be held jointly with the 44th Annual Meeting of the Japan Society of Brain Tumor Pathology (JSBTP2026).
- ASNO2026: June 12 (Fri) – 14 (Sun), 2026
- JSBTP2026: June 11 (Thu) – 12 (Fri), 2026
Abstract Submission Period
| Thursday, November 20, 2025 at 12:00 PM (JST) – | Thursday, January 20, 2026 at 12:00 PM (JST) |
Thursday, November 20, 2025 at 12:00 PM (JST) – Thursday, January 20, 2026 at 12:00 PM (JST)
Presentation Style/Categories
General Presentation style
Oral presentation, Poster presentation (Poster style)
- *
- The final presentation format will be determined by the Congress President based on the review results.
General Presentation category
Category A Basic / Translational Science
| 1 | Angiogenesis & Invasion |
2 | Cell Biology / Metabolism / Stem Cells |
3 | Signaling Pathways / Drug Resistance |
4 | Genetics / Epigenetics |
|---|---|---|---|---|---|---|---|
| 5 | Experimental Therapeutics / Preclinical Studies |
6 | Computational Omics |
7 | Tumor Biology / Models |
8 | Immunology / Tumor Immunology |
| 9 | Basic Others |
Category B Clinical Research
| 1 | Adult Clinical Trials / Therapeutic Studies |
2 | Pediatric Clinical Trials / Therapeutic Studies |
3 | Immunotherapy / Precision medicine |
4 | Surgical / Intraoperative Therapy / Monitoring |
|---|---|---|---|---|---|---|---|
| 5 | Radiation Therapy | 6 | Novel Therapy | 7 | Molecular Pathology / Classification / Biomarkers |
8 | Neuroimaging / AI |
| 9 | Neuro-Cognitive Function / QoL / Patient Care / Palliative Care |
10 | Glioma | 11 | PCNSL | 12 | CNS Metastasis |
| 13 | Meningioma | 14 | Other Brain Tumors / Hereditary Disease |
15 | Rare Case Series | 16 | Clinical Others |
Category C Cross-cutting Themes
| 1 | Survivorship | 2 | Quality of Life | 3 | Health Services / Quality Improvement |
4 | Epidemiology / Outcomes Research |
|---|---|---|---|---|---|---|---|
| 5 | Health Disparities / Equity |
Category D Late-Breaking
| 1 | Late-Breaking Abstracts |
|---|
Abstract Acceptance or Rejection
Please note that the acceptance or rejection of abstracts, as well as the presentation format, is at the sole discretion of the Congress President.
Abstract Submission
Language for abstract
English
Language for presentation
English
Language for presentation slides
English
Abstract Format
| Title: | Up to 100 characters (no abbreviations or punctuation marks recommended) |
|---|
| Length: | Up to 1,400 characters (including spaces) |
|---|
| Abstract Body: | Background, Methods, Results, Conclusion |
|---|
| Figures/Tables: | Not allowed |
|---|
| Keywords: | 3–5 words |
|---|
- *
- Please note that the abstract will be published as submitted. We kindly ask you to carefully check for any typographical or grammatical errors before submission.
Ethical and Scientific Considerations
All studies involving human subjects or animals must have received appropriate ethical approval at the respective institution.
Case reports should ensure patient anonymity.
The presenting author must disclose any Conflict of Interest (COI) relevant to the submitted work at the time of conference presentation.
Review Process
All abstracts will be peer-reviewed by members of the Scientific Committee under a double-blind review system.
Evaluation criteria include: Scientific quality, Originality, Clarity of presentation, Relevance to neuro-oncology
Notification and Publication
Notification of acceptance, presentation format, and schedule will be sent to the corresponding author by e-mail in late April 2026.
Accepted abstracts will be published in the ASNO 2026 Abstract Book.
No corrections or revisions will be accepted after the submission deadline.
Abstract Submission
You may revise or delete your submitted abstract as many times as necessary before the submission deadline.
Please note that no changes can be made after the deadline.
To change or update your registration information, please click the “Confirmation / Modification” button.
For International Participants
For Japanese Participants
This system is confirmed to work with Google Chrome, Microsoft Edge, and Safari.
Please do not use any other browser.
Safari is supported on version 2.0.3 (417.9.2) or later. Older versions are not compatible.
Inquiries
Secretariat of the 21st Annual Meeting of the Asian Society for Neuro-Oncology
c/o Japan Convention Services, Inc.
14F Daido Seimei Kasumigaseki Bldg.
1-4-2, Kasumigaseki, Chiyoda-ku,
Tokyo 100-0013, Japan
E-mail: asno2026[A]convention[D]co[D]ip ( Please change [A] to @ and [D] to . )